Trial intelligence / Profile preview

Phase II study of asciminib in pediatric Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase

CTR20261516Phase 2Active

Sponsor

Novartis

Start

Jun 2026

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1